Articles tagged with Cancer
Researchers discovered hundreds of potential new cancer driver genes through splicing analysis, expanding therapeutic targets. The study found little overlap between splicing and mutation-driven cancer drivers, revealing a new class of potential cancer drivers that can be targeted independently.
A recent study reveals racial disparities in cancer stage at diagnosis and survival for adolescents and young adults, highlighting the need for tailored interventions to achieve cancer care equity. The findings support health policy and funding implications, emphasizing the importance of addressing these disparities.
Two studies reveal key proteins involved in micronuclear collapse, including p62 and CHMP7, which can serve as prognostic markers and therapeutic targets for high-CIN tumors. Oxidative damage from ROS triggers the process, causing chromosomal instability and DNA damage that fuels cancer progression.
Researchers at Osaka Metropolitan University found compounds in nucleic acids from salmon DNA and torula yeast RNA inhibit cancer cell growth. These compounds may prevent cancer by stopping cell replication.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
Researchers at Cold Spring Harbor Laboratory have discovered a strategy to kill breast cancer cells and shrink tumors by depriving them of two vital nutrients: glutamine and its backup supply, alpha-ketoglutarate. This approach was successful in lab experiments and effective in treating tumors in mice.
Researchers developed AI tool AINU to differentiate cancer cells from normal cells and detect early stages of viral infection. The tool scans high-resolution images of cells at nanoscale resolution, enabling it to detect subtle changes in cell structure that are too small for human observers.
A simple blood test could identify individuals with type 2 diabetes who are at a higher risk of certain cancers. The study found that higher levels of pro-inflammatory cytokine interleukin-6 were associated with an increased risk of obesity-related cancers.
A study found that counties with higher levels of structural racism had a 7.8-times higher estimated risk of developing cancer from traffic-related air pollutants, emphasizing the need for policies to address racial inequalities in exposure to carcinogenic traffic pollution.
A team of chemists at Scripps Research has mapped over 300 small molecule-reactive cancer proteins and their binding sites, revealing key protein targets that can be disrupted with certain chemical compounds to halt cancer cell growth. The findings have the potential to lead to more effective and precise cancer treatments.
A Ludwig Cancer Research study has identified PPARβ/δ, a master regulator of gene expression, as essential to the generation of memory T cells, which confer lasting immunity. The study also shows that the switch's dysfunction compromises T cell 'memory' and anti-cancer immune responses in mice.
A computational model can predict which drugs will be most effective in treating diseases caused by mutations that bring protein synthesis to a halt. The predictive model, RTDetective, accelerates the design, development, and efficacy of clinical trials for genetic disorders and cancers.
A new treatment approach has been confirmed effective in a major study, showing that locally advanced rectal cancer patients can experience complete tumour disappearance without needing surgery. This method reduces the risk of recurrence and preserves normal bowel function, offering a promising alternative to traditional treatments.
A new study reveals that fasting helps regenerate and heal intestinal injuries, but also increases the risk of developing early-stage intestinal tumors in mice. The researchers identified a pathway enabling this enhanced regeneration, which is activated during refeeding after fasting.
Researchers have identified HLA-E as a critical negative regulator of NK cell interactions with cancer cells. Disrupting NKG2A:HLA-E interactions may stimulate both NK cell and cytotoxic T cell effector functions against cancer, offering a promising anti-cancer strategy.
A cross-sectional study found that approximately 50% of cancer survivors experience financial hardship, with social vulnerability playing a key role in increasing levels of hardship. Younger, Medicare or Medicaid beneficiaries, and those with advanced disease are particularly vulnerable to financial strain.
Researchers developed alternative criteria using a prediction model to identify people with the most to gain from lung cancer screening. The study found that high-benefit groups include those who smoked for a long duration but at a lower intensity, heavy smokers who quit over 15 years ago, and racial and ethnic minority groups.
Researchers explore the phenomenon of liquid-liquid phase separation (LLPS) in relation to cancer and neurodegenerative diseases. LLPS is characterized by the spontaneous formation of segregated liquid-phase regions within cells, which can lead to the formation of aggregates and dysregulation of signaling pathways.
Researchers report a case of undifferentiated spindle cell sarcoma with primary insensitivity to standard chemotherapy, but a pronounced response to BRAF/MEK inhibitors at recurrence. The tumor was found to be BRAF exon 15 double-mutated: c.1799T>A p.V600E and c.1819T>A p.S607T.
A Rice University-led team is developing an affordable system to improve tumor removal accuracy for breast and head and neck cancer. The AccessPath system enables rapid, automatic tumor margin classification, revolutionizing real-time surgical guidance.
A new study provides a detailed map of healthy breast cells, shedding light on how breast cancer develops and the genetic ancestry-dependent variability in breast tissue. The research aims to identify new treatment targets and improve understanding of breast cancer development.
A cohort study found an association between cannabis-related disorder and the development of head and neck cancer. The study highlights the need for further research on the mechanism of this association and dose response to support evidence of cannabis use as a risk factor.
A recent study found that nearly half of cancer institutions lack adequate translation services, leading to difficulties recruiting minority patients. The study highlights the need for improved language equity in clinical trials to ensure equitable access to treatments.
A modeling study estimates that cancer screening costs over $40 billion annually in the US, with an emphasis on enhancing equitable access to recommended screenings. However, experts argue that this estimate may underestimate the true cost due to lack of consideration for subsequent testing, ineligible patients, and overdiagnosis.
A cohort study found that aspirin use was associated with a greater absolute reduction in risk of colorectal cancer among individuals with less healthy lifestyles. Lifestyle risk factors may help identify those with a more favorable risk-benefit profile for cancer prevention with aspirin.
Researchers predict that circular RNAs will play a crucial role in cancer diagnosis and treatment, enabling innovative diagnostic and therapeutic developments. The study highlights the potential of circRNAs as biomarkers, therapy targets, and even immune response inducers against cancer cells.
Researchers identified areas with lower colorectal cancer screening rates and developed an interactive web map to pinpoint neighborhood-level disparities. The study aims to inform targeted education or intervention programs, ultimately increasing screening rates in priority neighborhoods and contributing to national improvements.
Research from Hiroshima University Hospital found that YAP/TAZ interactions with RBM39 delay the degradation of RBM39 by indisulam, thereby reducing its effectiveness and conferring resistance. This mechanism may aid the development of a new therapeutic approach for patients with solid cancers including HNSCC.
A recent study published in Frontiers found that pesticide use is associated with increased cancer risk, particularly for Non-Hodgkins lymphoma, leukemia, and bladder cancer. The researchers discovered a strong correlation between pesticide exposure and cancer incidence, rivalling the effects of smoking.
Researchers found that type II innate lymphoid cells transform after a cancer patient receives stem cells from a donor, preventing an effective immune system rebuilding. This new understanding may lead to better strategies for enhancing immune system recovery post-transplantation.
Women with bilateral mastectomy have a greatly diminished risk of contralateral breast cancer, yet experience similar mortality rates as patients treated with lumpectomy or unilateral mastectomy. The study highlights the importance of considering long-term risks and benefits in breast cancer treatment decisions.
The American College of Chest Physicians has released a new clinical guideline for managing central airway obstruction, providing evidence-based recommendations to guide its management. The guideline emphasizes the importance of shared decision-making and a multidisciplinary approach in optimizing care and improving outcomes.
A new AI model can identify certain stages of ductal carcinoma in situ (DCIS), a type of pre-invasive breast cancer, that are likely to progress to invasive cancer. The model uses imaging and machine learning to analyze tissue samples and determine the stage of DCIS based on cell arrangement and organization.
A new study published in Aging explores the potential of three large DNA methylation datasets to identify biological age signals in dogs. The researchers found that biological age methylation clocks are affected by population stratification and require heavy parameterization to achieve effective predictions.
A team of researchers from Penn State College of Medicine identified KDR, a tyrosine kinase, as a potential drug target for treating diseases caused by human T-cell leukemia virus type 1 (HTLV-1). By blocking KDR, the viral protein Tax is degraded, leading to cell death and disruption of cancer-causing signaling pathways.
A novel strategy using venetoclax and azacitidine demonstrates significant anti-cancer effect with mild toxicity for relapsed/refractory AML patients. The treatment showed markedly better survival rates after one year compared to a control group, with improved 'graft-versus-leukemia effects' via alterations of immune cells.
Researchers created a new cell model to study the effects of senescence on lung fibroblasts. Senescent alveolar epithelial cells triggered fibrotic activation in lung fibroblasts, which was attenuated by senolytic therapy.
Researchers discovered that deactivating IL-11 increases healthy lifespan by 20-25% in mice, with reduced cancer deaths, fibrosis, chronic inflammation, and improved muscle strength. The findings raise the possibility of using anti-IL-11 treatments to study aging in humans.
Research reveals that ancient viruses can play a critical role in helping cancer survive and thrive. Silencing certain endogenous retroviruses may make cancer treatments work better by turning off nearby gene expression.
Experts have established a comprehensive guideline for classifying and treating advanced liver cancer in China. The guidelines recommend personalized treatment options based on tumor characteristics, vascular tumor thrombus grade, distant metastasis, liver function status, portal hypertension, and hepatitis B virus replication status.
A new study found that an electronic health record (EHR)-based nudge intervention significantly decreased low-value axillary surgery in older women with clinically node-negative, HR+/HER2− breast cancer. The user-friendly intervention could be beneficial for other practice settings or patient populations.
The study found that exercise increased PEDF levels in skeletal muscles and suppressed senescence markers in the lungs. PEDF also reduced senescence markers in multiple tissues and attenuated decline in respiratory function in pulmonary emphysema mouse model, suggesting its potential as a therapeutic agent for age-related diseases.
A retrospective cohort study found hormone-modulating therapy protected against Alzheimer's disease and related dementias in postmenopausal women with breast cancer. The protective effect varied by age and race, with greater benefit for Black women under 75.
A cross-sectional study found that men from disadvantaged neighborhoods had higher stress-related gene expression in their prostate tumors. This association suggests a potential link between neighborhood factors and aggressive prostate cancer.
Researchers at the University of Plymouth have discovered that administering a HDAC6 inhibitor prior to radiotherapy can inhibit cellular growth and increase cell death in meningioma samples. This promising approach could lead to improved treatment outcomes for malignant meningioma patients.
Researchers found increased liver oxidative stress and impaired antioxidant defenses in a DS murine model. The study suggests potential therapeutic strategies targeting oxidative stress and lipid metabolism to prevent or mitigate liver-related complications.
Researchers investigate chemical modifications to genetic regulation mechanisms, finding that Set8 controls gene activity through a mechanism other than histone modification. This study refines our understanding of genetic regulation relevant to human diseases like cancer.
Researchers discuss the critical role of the retinal pigmented epithelium in human vision and its susceptibility to aging. The study highlights the importance of understanding molecular and cellular mechanisms driving age-related pathological changes in vision decline.
Researchers have found that blocking Interleukin-6 (IL-6) from binding to neurons in the area postrema prevents cachexia in mice. This breakthrough discovery could lead to the development of new drugs targeting these neurons, potentially treating cancer cachexia and improving patients' quality of life.
The study identified RNF144B as a tumour suppressor that prevents genomic instability, but low expression leads to poor prognosis and treatment resistance in lung adenocarcinoma. The research suggests that even non-mutated genes like RNF144B can have a significant impact on cancer development.
Researchers found GLP-1 receptor agonists lower risks of certain obesity-associated cancers in patients with type 2 diabetes, suggesting potential benefits for cancer prevention in high-risk populations. The study provides preliminary evidence supporting further preclinical and clinical studies to prevent specific obesity-linked cancers.
A team of Penn State researchers has created a modular genetic circuit that turns cancer cells into a 'Trojan horse,' causing them to self-destruct and kill nearby drug-resistant cancer cells. The circuit outsmarts resistance and eliminates it before the cancer cells can evolve.
A study led by UPF describes the mechanism behind insulinoma formation, a rare type of pancreatic beta cell tumor. The research reveals that a change in the epigenetic pattern of beta cells leads to the accumulation of mutations and excessive insulin production.
A new genomic test has improved clinical care for some children with cancer in England by informing individual patient care. The study found that the test provided additional insights that improved care for 20 children and reduced the number of tests required.
The study identified 72 genes commonly expressed in chronically activated CD8+ T cells across seven types of cancer. One gene, CXCR6, supports the survival of these cells by promoting CD28 signaling. This finding may inform targets for broadly active cancer therapies and treatments.
An Italian study found that adherence to the Mediterranean Diet after a cancer diagnosis is associated with reduced mortality, especially from cardiovascular disease. Participants who followed a high-Mediterranean-Diet pattern had a 32% lower risk of mortality compared to those with lower adherence.
The University of Texas at Arlington's Junha Jeon is developing transition metal-free cross-coupling technologies using arynes to deliver medications safely and effectively. This project aims to improve the production of drugs, particularly for cancer treatment, by reducing impurities left behind by metals.
A new study has identified potential cancer drivers hidden in so-called 'junk' regions of DNA, which could lead to early diagnosis and new treatments. The discovery reveals mutations in previously overlooked regions of the genome that may contribute to the formation and progression of at least 12 different cancers.
A phase 2 study found fluorine-18 PSMA-1007 PET/computed tomography to be superior to multiparametric MRI for locoregional staging of prostate cancer. The technology supports its use in the preoperative workflow for intermediate-risk and high-risk tumors.
Researchers develop optogenetic system to precisely target cancer cells using light, inducing inflammatory cell death and triggering immune response. The approach aims to modulate the immune suppressive environment around cancer cells, helping T cells recognize and attack the disease.